Burke Neurological Institute
Menu
Skip to main content
Our Team
Contact Us
Donate
Clinical Trials
Search form
Search
About Us
Conditions
Faculty & Cores
News & Impact
Future Talent
Events
About Us
+
About the Institute
Our Mission & Vision
Our History
Our Leadership
Our Boards
Our Team
Affiliations & Partners
Funding Sources
Brand Toolkit
Research Compliance
Campus Guide
Covid-19 Guidelines for Vendors
Contact Us
Conditions
+
Neurological Conditions
Stroke
Spinal Cord Injury
Traumatic Brain Injury
Cerebral Palsy
Neurodegenerative Diseases
Retinal Degenerative Diseases
Neurological Recovery
Motor Recovery
Pain & Sensory Recovery
Cognitive Recovery
Vision Recovery
Find a Clinical Trial
Inquire About Trials
Research Registry
Center for Pain & Sensory
Center for Vision Repair
Resilience Program
Campus Guide
Faculty & Cores
+
Research Labs & Cores
Cho Lab
Friel Lab
Gibson Lab
Hollis Lab
Marshel Lab
Prusky Lab
Ratan Lab
Sahni Lab
Willis Lab
Yoshida Lab
Imaging Core
SCI Core
Research Methods
News & Impact
+
Recent News & Impact
News
Publications
Grants
Presentations
Future Talent
+
Programs & Opportunities
Open Job Positions
Summer Science
Intro to Neuroscience
NeuroAcademy
Postdoctoral Fellow
Graduate Medical Fellow
Undergraduate
High School
Events
+
Upcoming Events
Archived Events
Webinar Series
Gibson Lab
News & Impact
Focus
People
Projects
Impact
Clinical Trials
You are here
Home
>
Glucose Metabolism as a Therapeutic Target in Alzheimer’s Disease
Glucose Metabolism as a Therapeutic Target in Alzheimer’s Disease
PRESENTATION:
Grand Rounds
October 2017
Venue:
NYC Health + Hospitals/Lincoln, Bronx, NY
Featured Researchers
Gary E. Gibson, Ph.D.
Lab Director
Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration
Professor
Weill Cornell Medicine
Associated
Research Labs:
Gibson Lab
Conditions & Recovery
Cognitive Recovery
Remember and speak clearly.
Neurodegenerative Diseases
Worldwide, 50 million people are living with Alzheimer's and other dementias.
Research Methods
Metabolism
